Journal article
The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
Abstract
The presence of visceral metastases is adversely prognostic in men with metastatic castration-resistant prostate cancer (mCRPC), but the prognostic impact of the site of visceral metastasis is unclear. Men with mCRPC in the TAX 327 phase 3 trial receiving docetaxel or mitoxantrone every 3 wk or weekly docetaxel, each with prednisone, were analyzed retrospectively to study the impact of the site of visceral metastasis on overall survival (OS). …
Authors
Pond GR; Sonpavde; de Wit R; Eisenberger MA; Tannock IF; Armstrong AJ
Journal
European Urology, Vol. 65, No. 1, pp. 3–6
Publisher
Elsevier
Publication Date
1 2014
DOI
10.1016/j.eururo.2013.09.024
ISSN
0302-2838